adenine has been researched along with Schizophrenia in 10 studies
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is restricted due to the risk of potentially life-threatening side effects, such as agranulocytosis." | 8.12 | Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. ( Hashimoto, N; Ishikawa, S; Kusumi, I; Takanobu, K, 2022) |
"The impact of genetic polymorphism of CYP1A2 that are related to the induction of the isozyme on the plasma levels of haloperidol (HAL) in 40 male smokers with schizophrenia was investigated." | 7.71 | Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia. ( Hirokane, G; Morita, S; Okawa, M; Shimoda, K; Someya, T; Takahashi, S; Yokono, A, 2002) |
"Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is restricted due to the risk of potentially life-threatening side effects, such as agranulocytosis." | 4.12 | Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. ( Hashimoto, N; Ishikawa, S; Kusumi, I; Takanobu, K, 2022) |
"The impact of genetic polymorphism of CYP1A2 that are related to the induction of the isozyme on the plasma levels of haloperidol (HAL) in 40 male smokers with schizophrenia was investigated." | 3.71 | Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia. ( Hirokane, G; Morita, S; Okawa, M; Shimoda, K; Someya, T; Takahashi, S; Yokono, A, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Takanobu, K | 1 |
Hashimoto, N | 1 |
Ishikawa, S | 1 |
Kusumi, I | 1 |
Benmessaoud, D | 1 |
Hamdani, N | 1 |
Boni, C | 1 |
Ramoz, N | 1 |
Hamon, M | 1 |
Kacha, F | 1 |
Gorwood, P | 1 |
Law, AJ | 1 |
Wang, Y | 1 |
Sei, Y | 1 |
O'Donnell, P | 1 |
Piantadosi, P | 1 |
Papaleo, F | 1 |
Straub, RE | 1 |
Huang, W | 1 |
Thomas, CJ | 1 |
Vakkalanka, R | 1 |
Besterman, AD | 1 |
Lipska, BK | 1 |
Hyde, TM | 1 |
Harrison, PJ | 1 |
Kleinman, JE | 1 |
Weinberger, DR | 1 |
Rico, B | 1 |
BOOTH, DA | 1 |
SMITH, BO | 1 |
Hashimoto, R | 1 |
Yoshida, M | 1 |
Ozaki, N | 1 |
Yamanouchi, Y | 1 |
Iwata, N | 1 |
Suzuki, T | 1 |
Kitajima, T | 1 |
Tatsumi, M | 1 |
Kamijima, K | 1 |
Kunugi, H | 1 |
Kempisty, B | 1 |
Sikora, J | 1 |
Lianeri, M | 1 |
Szczepankiewicz, A | 1 |
Czerski, P | 1 |
Hauser, J | 1 |
Jagodzinski, PP | 1 |
Jönsson, E | 1 |
Brené, S | 1 |
Lindblad, K | 1 |
Sharara, S | 1 |
Sedvall, G | 1 |
Schalling, M | 1 |
Ujike, H | 1 |
Yamamoto, A | 1 |
Tanaka, Y | 1 |
Takehisa, Y | 1 |
Takaki, M | 1 |
Taked, T | 1 |
Kodama, M | 1 |
Kuroda, S | 1 |
Shimoda, K | 1 |
Someya, T | 1 |
Morita, S | 1 |
Hirokane, G | 1 |
Yokono, A | 1 |
Takahashi, S | 1 |
Okawa, M | 1 |
10 other studies available for adenine and Schizophrenia
Article | Year |
---|---|
Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels.
Topics: Adenine; Antipsychotic Agents; Clozapine; Humans; Lithium Carbonate; Neutrophils; Schizophrenia; Sch | 2022 |
Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics.
Topics: Adenine; Adult; Algeria; Antipsychotic Agents; Clozapine; Diagnostic and Statistical Manual of Menta | 2008 |
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Topics: Adenine; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; B-Lymphocytes; Blotting, | 2012 |
Finding a druggable target for schizophrenia.
Topics: Adenine; Animals; Class I Phosphatidylinositol 3-Kinases; ErbB Receptors; Humans; Neuregulin-1; Phos | 2012 |
URINARY EXCRETION OF SOME PURINE BASES IN NORMAL AND SCHIZOPHRENIC SUBJECTS.
Topics: Adenine; Biomedical Research; Creatine; Creatinine; Guanine; Humans; Hypoxanthines; Purines; Schizop | 1964 |
Association analysis of the -308G>A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia.
Topics: Adenine; Adult; Chi-Square Distribution; Female; Gene Frequency; Guanine; Humans; Japan; Male; Middl | 2004 |
MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia.
Topics: Adenine; Bipolar Disorder; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Demography; Fema | 2007 |
Lack of expansion of cytosine adenine guanine trinucleotide repeat in the dentatorubral and pallidoluysian atrophy gene in Swedish schizophrenic patients.
Topics: Adenine; Alleles; Atrophy; Autoradiography; Chromosomes, Human, Pair 13; Cytosine; Dentate Gyrus; Gl | 1996 |
Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder.
Topics: Adenine; Adult; Alleles; Asian People; Bipolar Disorder; Case-Control Studies; Cytosine; Female; Gua | 2001 |
Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.
Topics: 5' Flanking Region; Adenine; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP1A2; Cytosine; E | 2002 |